Markets:

Overview

News

Currencies

International

Treasuries

Baxter International (NY:BAX)

17.68 -0.09 (-0.53%)

Streaming Delayed Price Updated: 11:45 AM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

February 28, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified...

Via StockStory

“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)… ↗

February 27, 2025

Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED.

Via Talk Markets

Topics Stocks Stocks / Equities

Demystifying Baxter Intl: Insights From 4 Analyst Reviews ↗

February 26, 2025

Via Benzinga

Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

February 25, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,...

Via StockStory

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

How Is The Market Feeling About Baxter Intl? ↗

December 24, 2024

Via Benzinga

Uncovering Potential: Baxter Intl's Earnings Preview ↗

November 07, 2024

Via Benzinga

3 Shareholder Yield Stocks For Growth And Dividends ↗

October 18, 2024

Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt.

Via Talk Markets

Exploring the top movers within the S&P500 index during today's session. ↗

February 24, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 24, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

February 20, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock ↗

October 01, 2024

Via Benzinga

Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook ↗

February 20, 2025

Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.

Via Benzinga

Topics Earnings

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

February 20, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars

February 20, 2025

Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue...

Via StockStory

Baxter Earnings: What To Look For From BAX

February 19, 2025

Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

What To Expect From Baxter’s (BAX) Q4 Earnings

February 12, 2025

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million ↗

February 07, 2025

Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 27, 2025

Via Benzinga

Confidence Is Just As Dangerous When It's Too Low As When It's Too High ↗

January 24, 2025

To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has risks, too.

Via Investor's Business Daily

Puerto Rico Blackout: 8 Stocks Affected By Island-Wide Power Outage ↗

December 31, 2024

Only around 12% of Puerto Rico's residents currently have electricity, according to Luma Energy, the power company servicing the island.

Via Benzinga

“Healthcare Left For Dead” Stock Market (And Sentiment Results) ↗

December 19, 2024

This afternoon felt like either a fund blew up or the margin clerks were taking a bunch of dumb over-leveraged money out to the woodshed to put them out of their misery.

Via Talk Markets

Topics Stocks / Equities

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

Baxter International: Dividend Cut Because Of Restructuring ↗

November 29, 2024

Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow.

Via Talk Markets

Topics Stocks / Equities

Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook ↗

November 08, 2024

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management.

Via Benzinga

Topics Economy

US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene ↗

October 18, 2024

The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies...

Via Benzinga

Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports ↗

October 15, 2024

Baxter International resumes IV fluid shipments from international sites after Hurricane Helene disrupted production at its North Carolina plant, which supplies 60% of U.S. IV fluids. FDA approves...

Via Benzinga

Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage ↗

October 09, 2024

U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter's facility due to Hurricane Helene, which compromises...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.